Clinical application of immunoassay for urinary total excretion of deoxypyridinoline in patients with osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 15, Issue 3, 1997, Pages 153-159

  Nakatsuka, Kiyoshi ^a   Miki, Takami ^a   Sekiya, Khchiro ^a   Kawakami, Hidetaka ^a   Hirota, Yoshiko ^b   Miura, Masakazu ^b   Obi, Yasue ^c   Nishizawa, Yoshiki ^a   Morii, Hirotoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c Gynecology Obi Clinic   (Japan)

Author keywords

Calcitonin; Hormone replacement therapy; Immunoassay; Osteoporosis; Pyridinium cross link

Indexed keywords

BIOCHEMICAL MARKER; CALCITONIN; DEOXYPYRIDINOLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; METABOLIC BONE DISEASE; OSTEOLYSIS; OSTEOPOROSIS; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030967874     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02489948     Document Type: Article

References (26)

1. Uebelhart D, Gineyts E, Chapuy M-C, Delmas PD (1990) Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 8:87-96
2. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ (1991) Evaluation of urinary hydroxypyridinium crosslink measurement as resorption markers in metabolic bone diseases. Eur J Clin Invest 21:310-315
3. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C (1991) Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639-644
4. Ohishi T, Kushida K, Takahashi M, Kawana K, Yagi K, Kawakami K, Horiuchi K, Inoue T (1994) Urinary bone resorption markers in patients with metabolic bone disorders. Bone 15:15-20
5. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T (1983) Analysis of pyridinoline, a crosslinking compound of collagen fibers in human urine. J Biochem (Tokyo) 94:1133-1136
6. Robins SP, Duncan A, Riggs BL (1993) Direct measurement of free hydroxypyridinium crosslinks of collagen in urine as a new marker of bone resorption in osteoporosis. In: Christiansen C, Overgaad K (eds) Osteoporosis. Osteopress Aps, Copenhagen, pp 465-468
7. Seyedin SM, Kung VT, Danloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF (1993) Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 8:635-641
8. Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F (1993) Immunoassay of pyridinoline crosslinks excretion in normal adults and in Paget's disease. J Bone Miner Res 8:643-648
9. Fledelius C. Riis BJ, Overgaad K, Christiansen C (1994) The diagnostic validity of urinary free pyridinoline to identify women at risk of osteoporosis. Calcif Tissue Int 54:381-384
10. Kamel S, Brazier M, Oicard C, Boitte F, Samson L, Desmet G, Sebert JL (1994) Urinary excretion of pyridinoline crosslinks measured by Immunoassay and HPLC techniques in normal subjects and in elderly patients with vitamin D deficiency. Bone Miner 26:197-208
11. Robins SP, Woitge H, Hesley R. Ju J, Seyedin S, Scibel MJ (1994) Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:1643-1649
12. Garnero P, Shin WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700
13. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD (1995) Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 10:641-648
14. Kanis JA. Melton LJ III, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141
15. Schlemmer A, Hassager C, Jensen SB, Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridinium crosslinks in premenopausal women. J Clin Endocrinol Metab 74:476-480
16. Aoshima H, Kushida K, Takahashi M, Ohishi T, Kawana K, Inoue T (1996) Circadian rhythm of the urinary crosslinks pyridinoline and deoxypyridinoline in normal humans and involutional osteoporosis. J Bone Miner Metab 14:83-88
17. Fujimoto D, Moriguchi T, Ishida T, Hayashi H (1978) The structure of pyridinoline: a collagen crosslinks. Biochem Biophys Res Commun 84:52-57
18. Black D, Duncan A, Robins SP (1988) Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reverse-phase high performance liquid chromatography. Anal Biochem 169:197-203
19. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN. Delmas PD, Deftos LJ, Raisz LG (1994) The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366-371
20. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks J Clin Endocrinol Metab 72:367-373
21. Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R (1993) Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 8: 881-889
22. Nakatsuka K, Miki T, Kawakami H, Nishizawa Y, Morii H (1995) Effects of salmon calcitonin on bone resorption assessed by urinary excretion of pyridinium cross-links in postmenopausal osteoporosis. (in Japanese) Osteoporosis Jpn 3:498-500
23. Nishizawa Y, Hagiwara S, Nakatsuka K, Aratani H, Miki T, Morii H (1995) Efficacy of low dose, intermittent eel calcitonin treatment for oseoporosis. J Bone Miner Metab 13:23-26
24. Kollerup G, Hermann AP, Brixen K , Lindblad BE, Mosekilde L, Sorensen OH (1994) Effects of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis. Calcif Tissue Int 54:12-15
25. Thamsborg G, Jensen JEB, Kollerup G, Hauge EM, Melsen F, Sorensen OH (1996) Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis. Bone 18:207-212
26. Kraenzlin ME, Seibel MJ, Trechsel U, Boerlin V, Azria M, Kraenzlin CA, Haas HG (1996) The effect of intranasal calcitonin on postmenopausal bone turnover as assessed by biochemical markers. Evidence of maximal effect after 8 weeks of continuous treatment. Calcif Tissue Int 58:216-220